Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies

Journal of the Neurological Sciences

Volumn 195, Issue 2, 2002, Pages 153-159

  Marui, Wami ^a   Iseki, Eizo ^a   Nakai, Toshiki ^a   Miura, Satoshi ^a   Kato, Masanori ^b   Uéda, Kenji ^c   Kosaka, Kenji ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b Soga Hospital   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Dementia with Lewy bodies; Immunohistochemistry; Lewy body; Lewy pathology; Lewy related neurite; Progression; Staging; Synuclein

Indexed keywords

ALPHA SYNUCLEIN;

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; ENTORHINAL CORTEX; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULA; LEWY BODY; LIMBIC CORTEX; NEOCORTEX; NEURITE; NEUROPATHOLOGY; PRIORITY JOURNAL; TEMPORAL CORTEX;

EID: 0037196894     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00006-0     Document Type: Article

References (26)

1. Diffuse Lewy body disease: clinical features in 15 cases
2. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB workshop
3. Lewy bodies in cerebral cortex. Report of three cases
4. Parkinson's disease. Distribution of Lewy bodies and monoamine neuron system
5. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree. A new disease?
6. Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly
7. A pathological study of Lewy bodies and senile changes in the amygdala in diffuse Lewy body disease
8. Lewy bodies are preferentially in limbic areas in diffuse Lewy body disease
9. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD
10. Hippocampal pathology in diffuse Lewy body disease using ubiquitin immunohistochemistry
11. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity
12. Accumulation of NACP/α-synuclein in Lewy body disease and multiple system atrophy
13. Clinicopathological multiplicity of dementia with Lewy bodies
14. Neuropathological stageing of Alzheimer-related changes
15. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease
16. Identification of two distinct synucleins from human brain
17. α-Synuclein in Lewy bodies
18. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
19. Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous components of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies
20. Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease
21. Immunoreactivity profile of hippocampal CA2-3 neurites in diffuse Lewy body disease
22. Degenerative terminals of the perforant pathway are human α-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease
23. A direct demonstration of the perforant pathway terminal zone in Alzheimer's disease using the monoclonal antibody Alz-50
24. Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using α-synuclein-immunohistochemistry
25. Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies
26. Occurrence of human α-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer's disease